CFO received an award of 159K ALKS derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Oct 8, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Oct 10, 2025
CFOGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001520262-25-000006
- Filed / recorded
Added to OQROOct 6, 2026, 9:54 PM UTC Data qualityVerified: identifiers matched exactly Reporting personJoshua Reed Officer titleSVP, Chief Financial Officer SecurityEmployee Stock Option (Right to Buy) TableDerivative (Table II) Transaction dateOct 8, 2025 Acquired / disposedAcquired (A) Shares owned after158,743 Footnotes from the filing
- Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 10/8/2026.
Around the same time
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$273K of Alkermes plc
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.